SpineGuard S.A.
ALSGD.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €2,120 | €2,203 | €2,446 | €2,079 |
| % Growth | -3.7% | -9.9% | 17.7% | – |
| Cost of Goods Sold | €456 | €518 | €502 | €468 |
| Gross Profit | €1,664 | €1,685 | €1,944 | €1,611 |
| % Margin | 78.5% | 76.5% | 79.5% | 77.5% |
| R&D Expenses | €659 | €543 | €813 | €960 |
| G&A Expenses | €719 | €746 | €776 | €803 |
| SG&A Expenses | €1,836 | €2,967 | €2,801 | €2,796 |
| Sales & Mktg Exp. | €1,118 | €1,846 | €2,025 | €1,993 |
| Other Operating Expenses | -€89 | -€377 | -€58 | -€137 |
| Operating Expenses | €2,407 | €3,133 | €3,556 | €3,620 |
| Operating Income | -€743 | -€1,825 | -€1,612 | -€2,009 |
| % Margin | -35% | -82.9% | -65.9% | -96.6% |
| Other Income/Exp. Net | -€341 | €346 | €10 | -€193 |
| Pre-Tax Income | -€1,083 | -€1,479 | -€1,603 | -€2,202 |
| Tax Expense | €0 | €0 | €0 | -€27 |
| Net Income | -€1,083 | -€1,479 | -€1,603 | -€2,175 |
| % Margin | -51.1% | -67.2% | -65.5% | -104.6% |
| EPS | -0.018 | -0.031 | -0.034 | -0.06 |
| % Growth | 41.3% | 7.4% | 43.4% | – |
| EPS Diluted | -0.018 | -0.031 | -0.034 | -0.054 |
| Weighted Avg Shares Out | 54,167 | 47,494 | 47,494 | 36,531 |
| Weighted Avg Shares Out Dil | 59,144 | 47,493 | 47,493 | 40,512 |
| Supplemental Information | – | – | – | – |
| Interest Income | €1 | €1 | €96 | €42 |
| Interest Expense | €328 | €130 | €165 | €193 |
| Depreciation & Amortization | €67 | €126 | €61 | €145 |
| EBITDA | -€675 | -€1,699 | -€1,548 | -€1,863 |
| % Margin | -31.9% | -77.1% | -63.3% | -89.6% |